149 related articles for article (PubMed ID: 2782949)
1. Immunoscintigraphy using CA 125 antibodies in the management of ovarian cancer.
Brökelmann J; Bockisch A; Vogel J; Reinsberg J; Oehr P; Biersack HJ; Krebs D
Arch Gynecol Obstet; 1989; 244(4):193-206. PubMed ID: 2782949
[TBL] [Abstract][Full Text] [Related]
2. [The detection of metastases of ovarian carcinoma by immunoscintigraphy with monoclonal antibodies].
Peking A; Marinov V
Akush Ginekol (Sofiia); 1990; 29(1):57-60. PubMed ID: 2164792
[TBL] [Abstract][Full Text] [Related]
3. Clinical immunoscintigraphy of recurrent ovarian cancer with indium 111-labeled B72.3 monoclonal antibody.
Krag DN; Ford P; Smith L; Taylor M; Schneider PD; Bushberg JT; Goodnight JE
Arch Surg; 1993 Jul; 128(7):819-23. PubMed ID: 8317965
[TBL] [Abstract][Full Text] [Related]
4. [Immunoscintigraphy of oncologic tumors].
Barzen G
Radiol Diagn (Berl); 1990; 31(3):209-20. PubMed ID: 2367627
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125.
Baum RP; Lorenz M; Hottenrott C; Albrecht M; Senekowitsch R; Happ J; Hertel A; Spitz J; Hör G
Int J Biol Markers; 1988; 3(3):177-84. PubMed ID: 3230337
[TBL] [Abstract][Full Text] [Related]
6. [Immunoscintigraphy of cancer of the ovaries and colon using labeled monoclonal antibodies].
Gabuniia RI; Shiriaev SV; Bogdasarov IuB; Zhordaniia KI; Anan'ev VS
Med Radiol (Mosk); 1989 Aug; 34(8):56-61. PubMed ID: 2770446
[TBL] [Abstract][Full Text] [Related]
7. Primary diagnosis and follow-up of ovarian cancer: radioimmunoscintigraphy with iodine-131 labeled OC 125 monoclonal antibodies versus computed tomography and "second look".
Barzen G; Hierholzer J; Cordes M; Friedmann W; Felix R
Int J Rad Appl Instrum B; 1991; 18(1):69-76. PubMed ID: 2010310
[No Abstract] [Full Text] [Related]
8. OC125 immunoscintigraphy in ovarian carcinoma: a comparison with alternative methods of assessment.
Maughan TS; Haylock B; Hayward M; Facey P; Evans WD; Shelley MD; Fish RG; Adams M
Clin Oncol (R Coll Radiol); 1990 Jul; 2(4):199-205. PubMed ID: 2261415
[TBL] [Abstract][Full Text] [Related]
9. Immunoscintigraphy of ovarian endometriosis. A preliminary study.
Kennedy SH; Soper ND; Mojiminiyi OA; Shepstone BJ; Barlow DH
Br J Obstet Gynaecol; 1988 Jul; 95(7):693-7. PubMed ID: 3166379
[TBL] [Abstract][Full Text] [Related]
10. Use of CA 125 monoclonal antibody to monitor patients with ovarian cancer.
Kudlacek S; Schieder K; Kölbl H; Neunteufel W; Nowotny C; Breitenecker G; Biegelmayer G; Vetterlein M; Fürlinger B; Micksche M
Gynecol Oncol; 1989 Dec; 35(3):323-9. PubMed ID: 2480931
[TBL] [Abstract][Full Text] [Related]
11. [Comprehensive diagnosis of cancer of the ovaries].
Korsunskiĭ VN; Tarasenko IuI; Ostrovskaia EIu; Stupakov IA; Mironova SP
Med Radiol (Mosk); 1989 Aug; 34(8):51-6. PubMed ID: 2549327
[TBL] [Abstract][Full Text] [Related]
12. The relationship between 111In-labelled immunoscintigraphy and serum CA-125 levels in ovarian carcinoma patients postchemotherapy.
Prosser ES; Pomeroy M; Barker F; Carroll K; Davis M; Duffy J; Duffy G; Fennelly JJ; O'Kennedy R
Biochem Soc Trans; 1992 Feb; 20(1):54S. PubMed ID: 1633979
[No Abstract] [Full Text] [Related]
13. Clinical implications for immunoscintigraphy in patients with ovarian malignancy: a preliminary study using monoclonal antibody 791T/36.
Symonds EM; Perkins AC; Pimm MV; Baldwin RW; Hardy JG; Williams DA
Br J Obstet Gynaecol; 1985 Mar; 92(3):270-6. PubMed ID: 3978057
[TBL] [Abstract][Full Text] [Related]
14. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma].
Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P
Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855
[TBL] [Abstract][Full Text] [Related]
15. Management of patients with ovarian cancer using monoclonal antibodies.
Lastoria S; Panza N; Esposito G; Vergara E; Castelli L; Caracò C; Battista C; Pacilio G; Salvatore M
Biomed Pharmacother; 1992; 46(10):453-63. PubMed ID: 1306360
[TBL] [Abstract][Full Text] [Related]
16. [Ovarian carcinoma antigen (CA 125) and ovarian cancer (clinical follow-up and prognostic studies)].
Göcze P; Vahrson H
Orv Hetil; 1993 Apr; 134(17):915-8. PubMed ID: 8479736
[TBL] [Abstract][Full Text] [Related]
17. 111In-CYT-103 immunoscintigraphy in ovarian cancer.
Cannistra SA
Gynecol Oncol; 1993 Nov; 51(2):292-4. PubMed ID: 8276314
[No Abstract] [Full Text] [Related]
18. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125.
Lehtovirta P; Kairemo KJ; Liewendahl K; Seppälä M
Cancer Res; 1990 Feb; 50(3 Suppl):937s-940s. PubMed ID: 2297745
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer].
Campos Villarino LM; Pajares Vinardell M; Freire Macias JM; Vale Gonsalves EI; Millán Núñez-Cortés J; Senra Varela A
An Med Interna; 1991 Aug; 8(8):377-81. PubMed ID: 1768746
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT.
Low RN; Carter WD; Saleh F; Sigeti JS
Radiology; 1995 May; 195(2):391-400. PubMed ID: 7724757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
